Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.

Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.

KL-6 is an antigen produced mainly by damaged type II pneumocytes that is involved in interstitial lung disease. Chronic lung allograft dysfunction (CLAD) after lung transplantation (LT) is a major concern for LT clinicians, especially in patients with restrictive allograft syndrome (RAS). We invest...

Full description

Bibliographic Details
Main Authors: Cristina Berastegui, Susana Gómez-Ollés, Alberto Mendoza-Valderrey, Thais Pereira-Veiga, Mario Culebras, Victor Monforte, Berta Saez, Manuel López-Meseguer, Helena Sintes-Permanyer, Victoria Ruiz de Miguel, Carlos Bravo, Judit Sacanell, María-Antonia Ramon, Laura Romero, María Deu, Antonio Román
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0226488

Internet

https://doi.org/10.1371/journal.pone.0226488

Similar Items